Chytła A,
Rattay S, Akgül B, Sztacho M. Plasma membrane and nuclear phosphatidylinositol
4,5-bisphosphate signalling in cancer. Lipids Health Dis. 2025 Feb 6;24(1):39.
doi: 10.1186/s12944-025-02452-6. PMID: 39915829; PMCID: PMC11800418.
Miladinović A, Antiga L, Venit T, Bayona‑Hernandez A, Červenka J, Labala RK, Kolář M, Castaño E, Sztacho M, Hozak P. The perinucleolar compartment and the oncogenic super‑enhancers are part of the same phase‑separated structure filled with phosphatidylinositol 4,5‑bisphosphate and long non‑coding RNA HANR. Adv Biol Regul. 2024 Nov 30:101069. doi: 10.1016/j.jbior.2024.101069. Epub ahead of print. PMID: 39648081.
Sztacho M, Červenka J, Šalovská B, Antiga L, Hoboth P, Hozák P. The RNA‑dependent association of phosphatidylinositol 4,5‑bisphosphate with intrinsically disordered proteins contribute to nuclear compartmentalization. PLoS Genet. 2024 Dec 2;20(12):e1011462. doi: 10.1371/journal.pgen.1011462. PMID: 39621780; PMCID: PMC11668513.
Hoboth P, Sztacho M, Hozák P. Nuclear patterns of phosphatidylinositol 4,5‑ and 3,4‑bisphosphate revealed by super‑resolution microscopy differ between the consecutive stages of RNA polymerase II transcription. FEBS J. 2024 Oct;291(19):4240‑4264. doi: 10.1111/febs.17136. Epub 2024 May 11. PMID: 38734927.